Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.01B P/E - EPS this Y - Ern Qtrly Grth -
Income -152.26M Forward P/E 288.44 EPS next Y 58.10% 50D Avg Chg 2.00%
Sales 651.76M PEG 13.80 EPS past 5Y -28.62% 200D Avg Chg -4.00%
Dividend N/A Price/Book 1.10 EPS next 5Y 12.00% 52W High Chg -35.00%
Recommedations 2.70 Quick Ratio 4.97 Shares Outstanding 53.92M 52W Low Chg 28.00%
Insider Own 1.96% ROA -1.55% Shares Float 48M Beta 1.51
Inst Own 106.60% ROE -5.95% Shares Shorted/Prior 4.61M/4.16M Price 46.15
Gross Margin 40.74% Profit Margin -23.12% Avg. Volume 1,114,354 Target Price 62.60
Oper. Margin -14.41% Earnings Date Aug 6 Volume 664,628 Change 0.07%
About Azenta, Inc.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta, Inc. News
05/13/24 Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
05/10/24 Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges
05/08/24 Azenta Announces CEO Succession Plan
05/08/24 Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
05/01/24 Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
04/09/24 Azenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate
04/01/24 Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
04/01/24 Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/12/24 Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
02/07/24 Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024
02/07/24 Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023
02/02/24 Azenta Launches the BioArcโ„ข Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
01/28/24 Investors in Azenta (NASDAQ:AZTA) have seen impressive returns of 117% over the past five years
01/11/24 Azenta to Host Investor Day on March 14, 2024
01/09/24 Azenta to Participate in the 26th Annual Needham Growth Conference
01/03/24 Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
01/01/24 Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?
11/21/23 Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference
11/14/23 Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript
11/13/23 Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure
AZTA Chatroom

User Image vinmee Posted - 3 days ago

$IOVA their sales and buyout will skyrocket $AZTA $LLY $MRNA

User Image Stock_Titan Posted - 5 days ago

$AZTA Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK https://www.stocktitan.net/news/AZTA/azenta-opens-the-doors-to-its-new-genomics-laboratory-in-oxford-46jqugw7e9zy.html

User Image Villidj_Idjit Posted - 1 week ago

$AZTA at support zone but it might not go anywhere for a while.

User Image G101SPM Posted - 1 week ago

$SPX 5207 +20.17 --- Establishing 5225 as resistance carries SPM 91.15 tag. #FIRSTLOOK 1:12 PM The major indices all show gains, trading near their best levels of the day. The S&P 500 above the 5,200 level, which acted as resistance earlier this week. Today's broad advance covers 25 of the 30 Dow components are higher and ten of the 11 S&P 500 sectors show gains. The real estate sector is the top performer, showing a 1.9% gain, followed by the consumer discretionary (+1.0%) and energy (+0.9%) sectors. ^ Some semiconductor stocks are an exception, underperforming compared to the broader market. The PHLX Semiconductor Index (SOX) is down 0.5% with many components showing losses. Azenta ($AZTA 51.36, -2.71, -5.0%) is the worst performing SOX component after reporting earnings. NVIDIA ($NVDA 891.16, -13.11, -1.5%) is another notable loser.

User Image Estimize Posted - 1 week ago

$AZTA beats the Estimize EPS Consensus by 1c and misses the Estimize Revenue Consensus by $1.40M. Reports FQ2 earnings of 5c EPS and $1... http://www.estimize.com/azta/fq2-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 1 week ago

$AZTA Azenta raises FY24 EPS guidance to 27c-37c, consensus 26c Lowers FY24 revenue guidance to $659M-$671M due to the timing of B Medical revenue, consensus $703.77M.

User Image DonCorleone77 Posted - 1 week ago

$AZTA Azenta reports Q2 EPS 5c, consensus 2c Reports Q2 revenue $159M, consensus $159.89M. "We saw continued momentum in the second quarter with strong organic revenue growth, and improved profitability as a result of our ongoing cost reduction and transformation initiatives," stated Steve Schwartz, President and CEO. "This marks our fourth consecutive quarter of positive free cash flow. And as noted during our Investor Day in March, we are confident in our position and the market opportunity which we are uniquely positioned to capture."

User Image epsguid Posted - 1 week ago

$AZTA reported earnings of $0.05, consensus was $0.02 via @eWhispers #epsbeat http://eps.sh/d/azta

User Image Stock_Titan Posted - 1 week ago

$AZTA Azenta Announces CEO Succession Plan https://www.stocktitan.net/news/AZTA/azenta-announces-ceo-succession-y75shedivdci.html

User Image Stock_Titan Posted - 1 week ago

$AZTA Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 https://www.stocktitan.net/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2024-ended-march-31-nd78rxgp6kgr.html

User Image Stock_Titan Posted - 2 weeks ago

$AZTA Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast https://www.stocktitan.net/news/AZTA/azenta-announces-fiscal-2024-second-quarter-earnings-conference-call-9ea7qz91zc1x.html

User Image DonCorleone77 Posted - 1 month ago

$AZTA Azenta initiated with a Hold at Jefferies Jefferies initiated coverage of Azenta with a Hold rating and $64 price target. The company's transformation is underway, but a lot of margin runway is already priced into the shares, the analyst tells investors in a research note. The company's transformation should result in above-average margin expansion that is compelling, but the stock already discounts a lot of this, says the firm.

User Image Stock_Titan Posted - 1 month ago

$AZTA Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report https://www.stocktitan.net/news/AZTA/azenta-publishes-its-2023-environmental-social-amp-governance-esg-q5u20u33x8kj.html

User Image Stock_Titan Posted - 1 month ago

$AZTA Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/AZTA/azenta-to-participate-in-the-23rd-annual-needham-virtual-healthcare-nahfs56cqmgb.html

User Image erevnon Posted - 03/28/24

Needham reiterates Azenta $AZTA at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image vinmee Posted - 03/22/24

$ESPR bullish on FDA news... $FUSN $AZTA

User Image Thestocktraderhubzee Posted - 2 months ago

WATCHLIST MAR 15 2024 $DKS Williams Trading Upgrades Dick's Sporting Goods to Buy, Raises Price Target to $235 $BLD B of A Securities Maintains Buy on TopBuild, Raises Price Target to $475 $AZTA Needham Maintains Buy on Azenta, Maintains $75 Price Target $NOTE EF Hutton Reiterates Buy on FiscalNote Holdings, Maintains $5 Price Target $MANU Deutsche Bank Maintains Hold on Manchester United, Lowers Price Target to $16

User Image Stock_Titan Posted - 2 months ago

$AZTA Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum https://www.stocktitan.net/news/AZTA/azenta-to-participate-in-the-virtual-key-banc-life-sciences-amp-med-mx37pyjrz1o2.html

User Image Thestocktraderhubzee Posted - 3 months ago

$AZTA Stephens & Co. Reiterates Equal-Weight on Azenta, Maintains $70 Price Target

User Image DonCorleone77 Posted - 3 months ago

$AZTA Azenta backs FY24 adjusted EPS view 19c-29c, consensus 25c Backs FY24 revenue view $696M-$718M, consensus $703.3M. Adjusted EBITDA margin expansion is expected to be approximately 300 basis points.

User Image DonCorleone77 Posted - 3 months ago

$AZTA Azenta reports Q1 adjusted cont ops EPS 2c, consensus (3c) Reports Q1 revenue $154M, consensus $151M. "First quarter results came in ahead of expectations as we continued to deliver against our objectives on the top and bottom line," stated Steve Schwartz, President and CEO. "We have made good progress on our cost reduction initiatives and are seeing the benefits of these actions. This quarter marked our third consecutive quarter of positive free cash flow. Even in a softer market environment, we remain positive about our position as we move through fiscal 2024, and we believe that the actions we have taken over the past several months will allow us to continue to outgrow the market."

User Image epsguid Posted - 3 months ago

$AZTA reported earnings of $0.07, consensus was $0.00 via @eWhispers #epsbeat http://eps.sh/d/azta

User Image Stock_Titan Posted - 3 months ago

$AZTA Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 https://www.stocktitan.net/news/AZTA/azenta-reports-first-quarter-results-for-fiscal-2024-ended-december-1ls1pu1zzwkw.html

User Image VirmoMopire Posted - 01/30/24

$AZTA Just spotted some interesting activity on this one. ๐Ÿง

User Image TrendyChart Posted - 01/23/24

$AZTA Triumph over resistance, path to gains. ๐Ÿš€

User Image TrendyChart Posted - 01/23/24

$AZTA A saga of Bearish momentum unfolds on the stock chart, where resistance falters, and the trend stands resolute, pointing towards a path of prosperity and financial growth. ๐ŸŒ

User Image TrendyChart Posted - 01/23/24

$AZTA The technical orchestra plays a tune of optimism on the stock chart, where the trend dances gracefully, and resistance trembles. ๐Ÿ“ˆ

User Image richardred Posted - 01/22/24

@GMoney100s not necessarily I just like the space plus the stock action has this headed up IMO. I used to be a stockholder of Brooks Automation, which is now has changed it its name to $AZTA. They were a leader in cryogenic freezers.

User Image tickeron Posted - 01/20/24

Is this good for your portfolio? $AZTA price may drop as it broke higher Bollinger Band. View odds of downtrend. https://srnk.us/go/4974274

User Image Last10K Posted - 4 months ago

$AZTA just filed with the SEC a Event for Officers https://last10k.com/sec-filings/AZTA/0001558370-24-000337.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=AZTA

Analyst Ratings
Needham Buy May 9, 24
Needham Buy Apr 8, 24
Evercore ISI Group In-Line Apr 4, 24
Jefferies Hold Apr 4, 24
Needham Buy Mar 28, 24
Needham Buy Mar 14, 24
Needham Buy Mar 7, 24
Stephens & Co. Equal-Weight Feb 8, 24
Needham Buy Feb 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Robertson Lindon G EVP & Chief Financia.. EVP & Chief Financial Officer Aug 19 Buy 57.62 4,350 250,647 100,571 08/22/22
McManus Matthew EVP & Chief Operatin.. EVP & Chief Operating Officer Aug 19 Buy 58.15 8,625 501,544 29,467 08/22/22
Crowley Kimberly SVP, Chief HR Office.. SVP, Chief HR Officer Apr 12 Sell 78.02 132 10,299 5,133 06/07/22
Vacha Robin SVP, GM BLS-Products SVP, GM BLS-Products Nov 20 Sell 69.62 6,490 451,834 18,575 11/20/20
SCHWARTZ STEPHEN S CEO CEO Nov 20 Sell 69.62 27,822 1,936,968 377,711 11/20/20
Robertson Lindon G EVP & Chief Financia.. EVP & Chief Financial Officer Nov 20 Sell 69.62 13,983 973,496 77,266 11/20/20
Joseph Jason SVP, General Counsel.. SVP, General Counsel, Secy. Nov 20 Sell 69.62 5,925 412,498 85,855 11/20/20
SCHWARTZ STEPHEN S CEO CEO Sep 17 Sell 45.17 69,291 3,129,874 346,043 09/17/20
SCHWARTZ STEPHEN S CEO CEO Sep 11 Sell 45.08 33,910 1,528,663 415,334 09/11/20